Cochlear implants (CIs) are neuroprosthetic devices that can provide a sense of hearing to deaf people. However, a CI cannot restore all aspects of hearing. Improvement of the implant technology is needed if CI users are to perceive music and perform in more natural environments, such as hearing out a voice with competing talkers, reflections, and other sounds. Such improvement requires experimental animals to better understand the mechanisms of electric stimulation in the cochlea and its responses in the whole auditory system. The mouse is an increasingly attractive model due to the many genetic models available. However, the limited use of this species as a CI model is mainly due to the difficulty of implanting small electrode arrays. More details about the surgical procedure are therefore of great interest to expand the use of mice in CI research.
Introduction
Cochlear implants (CIs) are electronic devices that can provide a sense of hearing to people with severe and profound hearing loss. It uses electrodes surgically implanted in the cochlea of the inner ear to directly stimulate the auditory nerve. To date, the CI is the most successful sensory prosthesis and has helped more than 600,000 people worldwide 1 . However, the device has shortcomings. First, the benefits provided by the device vary greatly among recipients. Second, speech in noisy environments and music are still poorly perceived by most CI users. For many years, animal models have been used to better understand these issues in CI research and to continuously improve safety and efficacy of the devices. The models have given valuable insight into several phenomena, such as plastic changes in the brain taking place following CI implantation 2 , the effect of applying gene therapy to preserve residual hearing 3 , and biophysical properties of the electrically stimulated auditory nerve 4 , among many other examples.
Mice are a powerful model organism due to the large availability of genetic models of deafness. Other advantages include the ability to manipulate the mouse genome (e.g., via the CRISPR-Cas system), the opportunity to use advanced imaging techniques to study mechanisms, particularly in the brain, the high reproduction rate, rapid development and easy breeding and handling. The main technical challenges in performing CI surgeries in mice are the small size of the cochlea and the presence of a large stapedial artery (SA). The SA usually disappears during embryonic development in humans but persists throughout life in a number of rodents, including mice, rats, and gerbils. The SA runs below the round window niche, which complicates access to the cochlea and increases surgical risk.
Previous studies have shown the feasibility of CI implantation in mice 5, 6, 7 . Irving et al. demonstrated that chronic intracochlear electrical stimulation can be achieved for up to one month. Acute stimulation was also performed but the recordings were not presented. They showed that cauterizing the stapedial artery had no significant effect on the hearing threshold or the number of spiral ganglion neurons and that topical application of the aminoglycoside neomycin, an ototoxic drug, was an effective deafening procedure in mice 5 . Soken et al. described a modified dorsal approach to the mouse cochlea through the round window to better preserve hearing status 6 . Following insertion of a platinum-iridium wire, substantial residual hearing was observed with an increased auditory brainstem response (ABR) threshold of 28 dB. Otoacoustic emissions (OAE) were lost in animals with large ABR threshold shifts 6 . Mistry et al. tested the functional and histopathological effects of implantation in the Copyright © 2019 Creative Commons Attribution 3.0 License January 2019 | 143 | e58073 | Page 2 of 9 absence of electric stimulation 7 . Even though hearing was preserved in both 3 and 6 months-old implanted mice at low frequencies, implantation resulted in fibrosis-like tissue around the implant and osteoneogenesis around the bullostomy 7 .
In short, out of the three studies on CIs in mice, only one demonstrates functional recording of CI stimulation. Irving and colleagues performed both acute and chronic eABR recordings but only showed data from chronic CI stimulation 5 . However, the chronic model with a fully implantable device developed by Irving et al. is technically challenging. It is not yet known if acute CI stimulation, both less challenging and faster, can achieve similar results.
CIs are used by people with severe and profound hearing loss who no longer benefit from hearing aids. Animal models for CI users should therefore include a deafening procedure when normally hearing animals are used. Another reason to deafen hearing animals is that the electrical stimulation of a deaf or hearing cochlea produces different neural responses 4, 8, 9, 10, 11, 12 . Electrical stimulation of a deaf cochlea directly activates the auditory nerve fibers and generates an electroneural response (α). It is characterized by short latency and a small dynamic range in the periphery 8, 10 . On the other hand, electrical stimulation of a hearing cochlea also excites the hair cells in an electrophonic response (β) that is characterized by longer latencies and larger dynamic range 4, 11 . The electrophonic response is attributed to normal excitation of nerve fibers by inner hair cells, electrically induced contraction of outer hair cells, and generation of a travelling wave 4 . Electroneural and electrophonic responses also result in two different activity patterns in the central nervous system 9 . Sato et al. recorded midbrain neurons of a CI implanted guinea pig before and after deafening with neomycin, which eliminates the electrophonic contribution. They showed that the slope of the ratelevel function was steeper and firing rates higher in the deafened condition compared to the hearing condition 9 . Therefore, depending on the research question stated, it is important to consider including deafening to separate electrophonic and electroneural responses upon electric stimulation of the auditory nerve.
Here, we describe the procedure for acute deafening and the cochlear implantation of an electrode array in a mouse as well as the functional recording of intracochlear electric stimulation with electrically-evoked auditory brainstem response (eABR).
Protocol
All procedures were carried out according to Basel University, Switzerland, animal care and guidelines. They were licensed by the Veterinary Office of the Canton of Basel, Switzerland. NOTE: C57BL/6 adult mice, aged 8-12 weeks (weight 20-30 g), were used in this study. The left ear is used as the experimental ear. The right ear serves as an intra-animal control and is not surgically altered. . Agents and dose regimes can be substituted per institutional guidelines. Notes: In general, the animal will need an injection every 45-60 min with this agent and dose regime. The average time from initial incision to closure around the implanted electrode array is typically 1-1.5 hours.
Preoperative Procedures
2. Check for full sedation of the animal marked by a regular breathing rate and a lack of toe-pinch reflexes. Maintain this level of anesthesia. 3. Maintain the animal's body temperature at 36.6 °C with a closed-loop heating pad. Apply eye ointment to avoid dehydration of the cornea. This will also suppress the animal's blink reflex, which can add noise to the recoding. 4. Administer local analgesic via subcutaneous injection (s.c.) of bupivacaine/Lidocaine (0.1 mg/mL bupivacaine and 0.4 mg/mL lidocaine, 0.1 mL administered s.c.) along the intended incision line to minimize any surgical discomfort. Agents and dose regimes can be substituted per institutional guidelines. 5. Administer the muscarinic antagonist atropine (atropinesulfate amino, 0.1 mg/mL, 20 μL administered s.c., dissolved in PBS) in the neck to reduce mucus secretion and to facilitate breathing. Agents and dose regimes can be substituted per institutional guidelines.
Pre-deafening Acoustic Auditory Brainstem Response (aABR)
NOTE: aABR is used to measure the status of hearing before and after deafening. Testing is performed on the left ear and in a soundproof electrically shielded booth. We recommend to test and later implant the left ear for a right-handed person. Further details on ABR in mice can be found in 13, 14 . Tucker Davis Technologies (TDT) hardware and software (BioSig) are used to record ABR but other systems can be used.
1. Block the contralateral (right) ear with acoustic foam to isolate the ABR response from the ipsilateral (left) ear. Put the foam in a 1 mL syringe and inject it into the right ear canal of the mouse to cover the whole ear canal with foam (0.1-0.2 mL of foam). Make sure the syringe seals closely to the ear so that the foam gets all the way into the ear canal. 2. Place the speaker 10 cm from the left ear.
NOTE: The speaker for this setup was calibrated using a PCB microphone as described in refefence 15 . 3. Clean the ABR electrodes with 70% ethanol solution. Place the electrodes under the skin: active (Ch1) on the vertex, reference (-) below the pinna of the ipsilateral ear, and ground in the hind leg (Figure 1) . 4. Connect the head-stage and pre-amplifier to the auditory processor via the optic fiber port. 5 . Check the impedance of the active and reference electrode.
1. If the impedance is over 3 Ohm, re-arrange them and re-take the measurement. The best recordings are obtained when the electrodes have the same impedance. Close the sound-proof booth.
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Surgery

NOTE:
Typical instruments used include a scissor, a scalpel, a pair of metallic forceps with straight or curved tips, a tissue retractor tool, several suction wedges and absorbable paper points. The surgery is performed on the left ear.
1. Put the mouse on its right side. Avoid undue torsional stress on the cervical vertebrae. Make sure to keep the body straight to keep the airways open. 2. Cut the fur behind the left ear with a scissor (or shave it with a shaver) to expose the skin. Sterilize the skin with 70% ethanol solution and betadine (povidone/iodine). 3. Under microscopic magnification (16x), make a 1-1.5 cm post-auricular incision with the scalpel. 4. Switch to higher microscopic magnification (25x). 5. Perform blunt dissection through the subcutaneous fat layer, which can be of variable thickness, with forceps.
NOTE: Be careful when dissecting as the external jugular vein traverses this area. Damage to this structure can cause excessive bleeding. 6. Retract the sternocleidomastoid muscle to reveal the tympanic bulla periosteum. Use the facial nerve as a key anatomical landmark to aid identification of the auditory bulla. The facial nerve wraps around the posterior/dorsal edge of the sternocleidomastoid muscle and runs rostrally along the ear canal towards the pinna. Gently place the self-retaining retractor tool in the incision to ease access to the bulla (Figure  4) . 7. Remove the tissue overlying the medio-dorsal area of the bulla to allow clear visualization of the ridge between the bulla and the mastoid process. 8. Gently rotate a 30 G needle to pierce the bulla and make a hole (bullostomy) on the posterior-superior side of the ridge (the bone is thinner on this side). Alternatively, use a dental surgical drill. NOTE: This and the following steps can be done with even higher microscopic magnification (40x) if preferred. Also, change the position of the microscope if needed. It is important to maximize the surgical view of the middle ear space. 9. Widen the bullostomy by pinching small bone pieces using fine tipped forceps to expose the middle ear cavity. Extend the bullostomy dorsally towards the mastoid process until the round window niche is clear of overlying bone. The stapedial artery, a branch of the internal carotid artery, runs ventral to the round window niche.
1. Be careful not to damage the vessel as excessive bleeding may be fatal. Small bleeds can be stopped by pressing a small piece of spongostan in the inner ear cavity. 2. Extend the bullostomy toward the anterior-superior direction to visualize the stapes, the middle ear bone connected to the oval window.
10. Remove the stapes with forceps to expose the oval window.
Round Window Application of Ototoxic Agent
1. Gently perforate the round window and oval window membranes using a blunted 30 G needle. Check that perilymph runs out. 2. Slowly perfuse 0.05% weight/volume neomycin dissolved in PBS (adjusted to pH 7.4) through the oval window. Liquid should flush out of the round window. Repeat the same procedure on the round window. Be careful not to damage the window bone structures with the needle used to perfuse. 3. Place a small piece (1 mm 2 ) of spongostan soaked in neomycin within the round window and oval window niche. 4. Remove the retractor tool, close the incision and wait 30 min.
Post-deafening Acoustic ABR
1. Record aABR in a similar way as before deafening (Steps 2.2 to 2.8) (Figure 2b, Figure 3 ).
Insertion of CI Electrode Array
NOTE:
The intracochlear electrode array consists of four platinum bands (Ø0.2 mm) with platinum/iridum parylene insulated wire shielded in a silicone tube (Figure 5 ).
1. Place the retractor tool in the incision to re-access the bulla. 2. Insert the electrode array into the round window (scala tympani) at a depth where the 4 th platinum ring is located just inside the round window.
This gives an insertion depth of ~2 mm, corresponding to an intracochlear position at ~30 kHz 16 . 3. Coil the lead wire inside the bulla and glue the wire to the tissue above the bulla. Coiling the wire helps to keep the array in place throughout the experiment. 4. Carefully remove the retractor and close the insertion with tissue glue. 5. Make a small incision (0.5 mm) in the neck perpendicular to the line between where the active and reference ABR electrodes will be using a tissue scissor. Place the platinum ground ball in the subcutaneous pocket and close the small incision with tissue glue (Figure 6 ). 6. Connect the electrode array board to the Animal Stimulator Platform.
Representative Results
The purpose of this study was to describe a reliable model for acute CI stimulation in the deafened mouse. Pre-and post-surgical hearing thresholds served as a functional readout of the deafening procedure. Topical application of 0.05% neomycin in the oval and round window significantly increased click-evoked hearing thresholds by 46 dB ± 6 (pre-vs post-neomycin: 30.0 dB ± 3.8 vs 75.7 dB ± 3.7, p = 0.0003, paired t-test, n= 7) (Figure 3) . The mouse-sized electrode array was hereafter inserted into the round window (Figure 4, Figure 5 ). Electric simulation of an intracochlear electrode could reliably generate eABR activity. (Figure 7) . In some cases, CI stimulation activated the facial nerve and produced a high amplitude wave with either short or long latency (Figure 8A and Figure 8B, respectively) . The short latency response was characterized by a rapid amplification of wave IV around 3 ms and is likely to be a direct response of the facial nerve. The long latency response appeared around 5-6 ms and is likely to be a non-auditory muscle (myogenic) response evoked indirectly by the facial nerve. Facial nerve responses are rarely reported in animal studies in literature but is a well-known complication in human CI users 17, 18, 19 . In Figure 8 , facial nerve stimulation appeared at relatively medium current levels (150-200 μA) and in two different animals. In other cases, both responses could appear in the same animal at very high current levels (not shown). We recommend limiting the current level to levels below the appearance of facial nerve stimulation. 
Discussion
This manuscript describes the surgical approach for acute deafening and cochlear implantation in the mouse, as well as the functional assessment of CI stimulation with auditory brainstem response. Although the mouse cochlea is small and the surgery challenging, the CI mouse model is feasible and serves as a valuable tool in auditory research.
The stapedial artery is present in the middle ear of the mouse. The artery enters the bulla posterior-medially, and runs inferiorly to the round window niche and then superiorly to the oval window niche. In the initial development of the mouse model, we experienced fatal intra-operative
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bleeding following trauma to the stapedial artery, mainly while accessing the bulla. As a consequence, we adapted a more limited approach and accessed the bulla in smaller, refined dissection steps. No further complications due to bleeding were thereafter observed. Despite the fact that stapedial artery cauterization has no significant effect on hearing threshold or number of spiral ganglion neurons in mice 5 , in our opinion, it is unnecessary so long as great care and attention are taken during the surgery. We suggest taking the time needed to develop fine psychomotor skills and reach technical proficiency. The average time from initial incision to closure around the implanted electrode array is typically 1-1.5 h.
The described acute CI surgery in mice is similar to the "ventral" procedure and round window insertion used in other rodents, including rats and gerbils 20, 21, 22 . Other rodent studies have used the "dorsal approach" with a basal turn cochleostomy instead of a round window insertion, avoiding the SA entirely and inserting the array more deeply 6, 23, 24 . The implantation of a chronic stimulation assembly in mice follows the same steps as described in this protocol with the addition of a Dacron mesh to fix the implant and postoperative care 5 .
The main technical challenges when performing CI surgeries in mice are the small size of the cochlea compared to the cochlea of rats and gerbils, and the presence of a large SA. The SA is also present in rats but not in gerbils. In addition, since mice are smaller than rats and gerbils, they are more vulnerable to surgical procedures.
To eliminate electrophonic responses in eABR recordings and to mimic hair cell loss found in most CI users, we deafened the animals before CI insertion. Mice are difficult to deafen ototoxically in vivo 25 because the systemic concentrations of aminoglycosides required to cause ototoxicity has a narrow dose window: lower doses given over several days results in no hair cell loss whereas a single injection of a higher dose can be lethal 26 . Also, susceptibility to aminoglycosides is strain dependent 26 . However, it has been shown that a single dose of aminoglycosides in combination with a loop diuretic can produce excessive outer hair cell loss in CBA/CaJ mice without fatal consequences 27 . Delayed inner hair cell death was reported in half of all cochleae examined 27 .
In this manuscript, we used topical application of the aminoglycosides neomycin inspired by the protocol recently established for C57BL/6 mice 5 . Acute application of neomycin significantly increased the click-evoked hearing threshold by 46 dB ± 6.1. Although this increase is larger than the 35 dB increase reported by Irving et al. (pre-vs post-surgery: 41.6 dB ± 3.3 vs 76.6 dB ± 4.4, p = 0.02, n = 3) 5 , we achieved the same postdeafening threshold (75.7 dB ± 3.7 vs 76.6 dB ± 4.4). 0.05% neomycin is thought to cause a partial loss of hearing, mainly by rapid outer hair cell death, as inner hair cell loss takes longer to occur 27 . It is therefore possible that electrophonic response, which is generated both by inner and outer hair cells 4, 8, 9, 10, 11, 12 , is only partially eliminated in deafened animals with residual hearing. Even though 0.05% (weight/volume) neomycin does not decrease the number of spiral ganglion neurons 4 weeks post-deafening 5 , it is yet unknown if neomycin in our acute setup affects the auditory nerve fibers or promotes synaptopathy (loss of synapses between inner hair cells and type I auditory nerve fibers). Another uncertainty is that the topical neomycin treatment may not produce a uniform distribution of hair cell loss along the length of the cochlea. Future studies are required to answer these questions.
In summary, the growing number of genetic models for human deafness and the biochemical tools available make the mouse an attractive animal model for auditory research, including the field of CIs.
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